Moreover, the therapeutic response can be affected by several parameters, such as the mutational load of GATA3+ cells, FOXP3+ cells and CD33+ cells and the abundance of TILs in lung cancer or melanoma (38–40). This evidence concerns the gene FOXP3 and lung carcinoma.